Walsh & Associates’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.5K Hold
120
– – 0.02% 154
2026
Q2
$23.4K Hold
120
– – 0.02% 158
2026
Q1
$26.9K Hold
120
– – 0.03% 141
2025
Q4
$28.9K Hold
120
– – 0.03% 141

Other funds holding RMD

Walsh & Associates's RMD Position: Q3 2026 in Review

Walsh & Associates held its ResMed (RMD) position steady in Q3 2026 at 120 shares worth $26.5K. The position accounts for 0.02% of the portfolio, ranked #154.

Walsh & Associates first reported a position in RMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $28.9K in Q4 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Walsh & Associates held 120 shares of ResMed worth $26.5K as of Q3 2026.
  • Walsh & Associates left its ResMed share count unchanged in Q3 2026.
  • ResMed made up 0.02% of Walsh & Associates's portfolio in Q3 2026, its #154 holding.
  • Walsh & Associates first reported a position in ResMed in Q4 2025 and has held it in 4 quarters since.
  • Walsh & Associates's ResMed position peaked at $28.9K in Q4 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.